# Leszek Tylicki

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/leszek-tylicki/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,694 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 24 |
| i10-index | 54 |
| Last Known Institution | Gdańsk Medical University |
| OpenAlex ID | https://openalex.org/A5087699203 |
| ORCID iD | 0000-0002-5515-5072 |
| Works | 148 |

## Researcher papers

- [Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial](https://scholariq.org/papers/triple-pharmacological-blockade-of-the-renin-angiotensin-aldosterone-system-in/)
- [Antioxidants: A Possible Role in Kidney Protection](https://scholariq.org/papers/antioxidants-a-possible-role-in-kidney-protection/)
- [Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis](https://scholariq.org/papers/low-dose-dual-blockade-of-the-renin-angiotensin-system-in-patients-with-primary/)
- [Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions](https://scholariq.org/papers/renin-angiotensin-aldosterone-system-blockade-for-nephroprotection-current/)
- [Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease](https://scholariq.org/papers/nonsteroidal-anti-inflammatory-drug-use-in-patients-with-chronic-kidney-disease/)
- [Beneficial Clinical Effects of Ozonated Autohemotherapy in Chronically Dialysed Patients with Atherosclerotic Ischemia of the Lower Limbs - Pilot Study](https://scholariq.org/papers/beneficial-clinical-effects-of-ozonated-autohemotherapy-in-chronically-dialysed/)
- [Predictors of Humoral Response to mRNA COVID19 Vaccines in Kidney Transplant Recipients: A Longitudinal Study—The COViNEPH Project](https://scholariq.org/papers/predictors-of-humoral-response-to-mrna-covid19-vaccines-in-kidney-transplant/)
- [Renal Protective Effects of the Renin-Angiotensin-Aldosterone System Blockade: From Evidence-Based Approach to Perspectives](https://scholariq.org/papers/renal-protective-effects-of-the-renin-angiotensin-aldosterone-system-blockade/)
- [Renoprotective Effect of Small Doses of Losartan and Enalapril in Patients with Primary Glomerulonephritis](https://scholariq.org/papers/renoprotective-effect-of-small-doses-of-losartan-and-enalapril-in-patients-with/)
- [Renal Allograft Protection with Angiotensin II Type 1 Receptor Antagonists L.](https://scholariq.org/papers/renal-allograft-protection-with-angiotensin-ii-type-1-receptor-antagonists-l/)
- [The Enhanced Renin-Angiotensin-Aldosteron System Pharmacological Blockade - Which is the Best?](https://scholariq.org/papers/the-enhanced-renin-angiotensin-aldosteron-system-pharmacological-blockade-which/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)

## Researcher university

- [Gdańsk Medical University](https://scholariq.org/institutions/gdansk-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.